TY - JOUR
T1 - Effects of verapamil on positive inotropic stimulation in the left atrium and ventricle of conscious dogs
AU - Goldman, S.
AU - Olajos, M.
AU - Morkin, E.
PY - 1982
Y1 - 1982
N2 - The interaction of verapamil with three known positive inotropic stimuli, ouabain, dopamine and postextrasystolic potentiation (PESP), was studied in 10 conscious dogs. Implanted sonomicrometer crystals and solid state pressure transducers were used to evaluate left atrial (LA) and left ventricular (LV) function while heart rate was held constant by atrial pacing. Ouabain (0.025 mg/kg) and dopamine (3-5 μg/kg/min) were administered in amounts sufficient in increase LV dP/dt by about 20%. PESP was achieved by using a programmed stimulator to introduce atrial premature beats. Each of these inotropic interventions caused significant (P < .05) increases in LV dP/dt, LV fractional shortening LV-velocity of circumferential fiber shortening (V(cf)) and LA-V(cf). Administration of a single i.v. dose of verapamil (0.03 mg/kg) caused no change in base-line mechanical and hemodynamic parameters. However, when verapamil was given during the increased inotropic state resulting from ouabain or dopamine administration, significant (P < .05) decreases occurred in LV dP/dt, LV fractional shortening, LA fractional shortening, LV-V(cf) and LA-V(cf). Verapamil did not alter the positive inotropic response to PESP in the LV or LA. Thus, a dose of verapamil that did not change resting indices of myocardial contractility depressed function significantly during positive inotropic responses to ouabain and dopamine. This negative inotropic effect seemed to be selective because verapamil did not alter the response to PESP.
AB - The interaction of verapamil with three known positive inotropic stimuli, ouabain, dopamine and postextrasystolic potentiation (PESP), was studied in 10 conscious dogs. Implanted sonomicrometer crystals and solid state pressure transducers were used to evaluate left atrial (LA) and left ventricular (LV) function while heart rate was held constant by atrial pacing. Ouabain (0.025 mg/kg) and dopamine (3-5 μg/kg/min) were administered in amounts sufficient in increase LV dP/dt by about 20%. PESP was achieved by using a programmed stimulator to introduce atrial premature beats. Each of these inotropic interventions caused significant (P < .05) increases in LV dP/dt, LV fractional shortening LV-velocity of circumferential fiber shortening (V(cf)) and LA-V(cf). Administration of a single i.v. dose of verapamil (0.03 mg/kg) caused no change in base-line mechanical and hemodynamic parameters. However, when verapamil was given during the increased inotropic state resulting from ouabain or dopamine administration, significant (P < .05) decreases occurred in LV dP/dt, LV fractional shortening, LA fractional shortening, LV-V(cf) and LA-V(cf). Verapamil did not alter the positive inotropic response to PESP in the LV or LA. Thus, a dose of verapamil that did not change resting indices of myocardial contractility depressed function significantly during positive inotropic responses to ouabain and dopamine. This negative inotropic effect seemed to be selective because verapamil did not alter the response to PESP.
UR - http://www.scopus.com/inward/record.url?scp=0019993662&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0019993662&partnerID=8YFLogxK
M3 - Article
C2 - 7086704
AN - SCOPUS:0019993662
SN - 0022-3565
VL - 222
SP - 270
EP - 275
JO - Journal of Pharmacology and Experimental Therapeutics
JF - Journal of Pharmacology and Experimental Therapeutics
IS - 1
ER -